BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,145 filers reported holding BAXTER INTL INC in Q4 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $532,000 | -8.1% | 6,616 | -1.5% | 0.19% | -9.5% |
| Q2 2020 | $579,000 | +2.3% | 6,720 | -3.6% | 0.21% | -11.0% |
| Q1 2020 | $566,000 | -1.9% | 6,973 | +1.0% | 0.24% | +16.7% |
| Q4 2019 | $577,000 | -5.4% | 6,903 | -1.1% | 0.20% | -9.0% |
| Q3 2019 | $610,000 | +4.6% | 6,978 | -1.9% | 0.22% | +3.2% |
| Q2 2019 | $583,000 | +1.2% | 7,113 | +0.5% | 0.22% | -1.4% |
| Q1 2019 | $576,000 | +24.4% | 7,078 | +0.6% | 0.22% | +12.3% |
| Q4 2018 | $463,000 | -16.6% | 7,036 | -2.2% | 0.20% | -0.5% |
| Q3 2018 | $555,000 | +4.3% | 7,194 | -0.1% | 0.20% | +1.6% |
| Q2 2018 | $532,000 | +90.7% | 7,199 | +67.7% | 0.19% | +89.2% |
| Q1 2018 | $279,000 | -0.7% | 4,292 | -1.4% | 0.10% | 0.0% |
| Q4 2017 | $281,000 | +2.9% | 4,353 | +0.1% | 0.10% | -1.9% |
| Q3 2017 | $273,000 | -10.5% | 4,348 | +5.0% | 0.10% | -13.3% |
| Q1 2014 | $305,000 | +22.0% | 4,139 | +14.9% | 0.12% | +20.0% |
| Q4 2013 | $250,000 | – | 3,601 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 16,850,000 | $1,473,870,000 | 17.51% |
| SECTOR GAMMA AS | 472,305 | $41,313,000 | 6.98% |
| TSFG, LLC | 91,132 | $7,971,000 | 6.10% |
| Veritas Asset Management LLP | 6,386,849 | $558,658,000 | 5.44% |
| Palmer Knight Co | 64,636 | $5,654,000 | 4.80% |
| Triodos Investment Management BV | 193,700 | $16,943,000 | 4.30% |
| Progressive Investment Management Corp | 82,216 | $7,191,000 | 3.85% |
| Alphinity Investment Management Pty Ltd | 362,173 | $31,679,000 | 3.65% |
| HealthCor Management, L.P. | 1,032,820 | $90,341,000 | 3.42% |
| Sivik Global Healthcare LLC | 75,000 | $6,560,000 | 3.31% |